HER2

January 23, 2019

Researchers Use Stem Cells to Produce Cancer-targeting Antibodies

News

In a new study, researchers have used stem cell proteins to create an antibody that can specifically recognize and be taken up by some types of breast and ovarian cancers. ... Read more

September 28, 2016September 28, 2016

Phase 1 Study of Treatment for Advanced HER2-Positive Cancers Gets Underway

News

A Phase 1 clinical trial assessing the safety and efficacy of the anti-HER2 antibody ZW25 in advanced or metastatic HER2-positive cancers has just dosed its first patient, according to a recent ... Read more

August 22, 2016August 22, 2016

FDA Speeds Testing of Two Therapies for Ovarian Cancer Targeting HER2

News

Zymeworks announced that the U.S. Food and Drug Administration (FDA) has granted its lead investigational products, ZW25 and ZW33, orphan drug designation as potential treatments for ovarian cancer (OC). The company’s lead therapeutic ... Read more